RIPK4 in melanoma: from signaling networks to therapeutic response

Melanoma heterogeneity and phenotypic plasticity remain major barriers to durable therapeutic responses. Although immune checkpoint blockade and MAPK-targeted therapies have substantially improved patient outcomes, primary and acquired resistance continue to limit long-term disease control. This has intensified efforts to identify molecular regulators that support tumor adaptation and may provide new therapeutic vulnerabilities. The review discusses mechanisms of therapeutic resistance in melanoma, current treatment limitations, and emerging molecular vulnerabilities. Within this landscape, RIPK4 has emerged as a context-dependent regulator of melanoma progression and therapeutic response. Experimental and clinical studies associate RIPK4 with tumor growth, invasion and metastatic behavior, while functional analyses link its activity to NF-κB, Wnt/β-catenin, FAK/AKT and MAPK-associated signaling. RIPK4 also influences responses to therapeutic stress with reported effects on ABCG2 abundance and survival-associated signaling, and its depletion can enhance melanoma sensitivity to BRAF inhibition, cytotoxic agents, vitamin D and melatonin. These findings support RIPK4 as a potential therapeutic vulnerability in melanoma, although its therapeutic potential remains to be established. Future studies should define the molecular determinants of RIPK4 dependency and develop selective inhibitors that distinguish kinase-dependent from non-catalytic functions.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-11-19
DOI
https://doi.org/10.3389/fphar.2026.2000456
Primary Topic
Melanoma and MAPK Pathways
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

RIPK4 in melanoma: from signaling networks to therapeutic response

Ewelina Madej, Agnieszka Wolnicka-Głubisz
Frontiers in Pharmacology
Melanoma and MAPK Pathways
article

RIPK4 in melanoma: from signaling networks to therapeutic response

Ewelina Madej, Agnieszka Wolnicka-Głubisz
article en

Abstract

Melanoma heterogeneity and phenotypic plasticity remain major barriers to durable therapeutic responses. Although immune checkpoint blockade and MAPK-targeted therapies have substantially improved patient outcomes, primary and acquired resistance continue to limit long-term disease control. This has intensified efforts to identify molecular regulators that support tumor adaptation and may provide new therapeutic vulnerabilities. The review discusses mechanisms of therapeutic resistance in melanoma, current treatment limitations, and emerging molecular vulnerabilities. Within this landscape, RIPK4 has emerged as a context-dependent regulator of melanoma progression and therapeutic response. Experimental and clinical studies associate RIPK4 with tumor growth, invasion and metastatic behavior, while functional analyses link its activity to NF-κB, Wnt/β-catenin, FAK/AKT and MAPK-associated signaling. RIPK4 also influences responses to therapeutic stress with reported effects on ABCG2 abundance and survival-associated signaling, and its depletion can enhance melanoma sensitivity to BRAF inhibition, cytotoxic agents, vitamin D and melatonin. These findings support RIPK4 as a potential therapeutic vulnerability in melanoma, although its therapeutic potential remains to be established. Future studies should define the molecular determinants of RIPK4 dependency and develop selective inhibitors that distinguish kinase-dependent from non-catalytic functions.

Frontiers in PharmacologyVol. 17
Jagiellonian University (PL)
Melanoma and MAPK Pathways
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon